. Author manuscript; available in PMC: 2014 Sep 16.

Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006627. doi: 10.1002/14651858.CD006627.pub2

Analysis 3.10. Comparison 3 ZIPRASIDONE versus OLANZAPINE, Outcome 10 General Functioning: 1. No clinically important change (less than 5 points improvement on GAF total score).

Review: Ziprasidone versus other atypical antipsychotics for schizophrenia

Comparison: 3 ZIPRASIDONE versus OLANZAPINE

Outcome: 10 General Functioning: 1. No clinically important change (less than 5 points improvement on GAF total score)